SACHS BRUCE I 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Aug 7, 2025
Insider Transaction Report
Form 4
SACHS BRUCE I
Director
Transactions
- Purchase
Common Stock
2025-08-06$389.36/sh+1,634$636,214→ 41,634 total - Purchase
Common Stock
2025-08-06$389.84/sh+3,366$1,312,201→ 45,000 total
Footnotes (3)
- [F1]Open market purchases reported on this line occurred at a weighted average price of $389.36 (range $388.61 to $389.60).
- [F2]Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
- [F3]Open market purchases reported on this line occurred at a weighted average price of $389.84 (range $389.61 to $390.00).